Introduction
The treatment of sunburn centers on reducing inflammation, limiting further skin injury, and supporting repair of damaged tissue. Sunburn is an acute inflammatory response to ultraviolet radiation, most often UVB, which injures epidermal cells and triggers the release of inflammatory mediators. This leads to redness, warmth, swelling, pain, and sometimes blistering. Treatment does not reverse all cellular damage immediately, but it aims to calm the inflammatory cascade, maintain the skin barrier, prevent complications such as dehydration or infection, and help the skin regenerate in an orderly way.
Management typically combines cooling measures, symptom-directed medications, protection from additional ultraviolet exposure, and, in more severe cases, medical assessment for complications. The common thread across these approaches is that they either reduce the local inflammatory response, protect damaged skin from further stress, or assist recovery while the epidermis repairs itself.
Understanding the Treatment Goals
The main goal of treatment is to reduce the intensity and duration of the inflammatory reaction caused by ultraviolet injury. UV radiation damages keratinocytes in the epidermis, creates oxidative stress, and activates signaling pathways that increase prostaglandins, cytokines, and other mediators of inflammation. These processes dilate superficial blood vessels and sensitize nerve endings, producing the classic symptoms of sunburn. Treatment is directed at these mechanisms rather than at the visible redness alone.
A second goal is to preserve the skin barrier. Sunburned skin loses water more easily because the outer layer is disrupted, which contributes to dryness, tightness, and peeling. By supporting hydration and minimizing additional irritation, treatment helps maintain barrier function while the skin recovers. A third goal is to prevent progression to more serious injury, including deeper tissue damage, fluid loss, and secondary infection in areas where blistering has disrupted the protective epidermis.
These goals guide treatment choices. Mild cases are usually managed with measures that reduce inflammation and discomfort. More extensive or complicated cases may require medical evaluation to assess hydration status, pain control needs, or the possibility of systemic effects such as fever or heat-related illness. The treatment plan therefore follows the severity of tissue injury and the degree of physiologic stress produced by the burn.
Common Medical Treatments
Topical cooling and moisturization are among the most common interventions. Cool compresses or brief cooling baths lower skin temperature and reduce vasodilation, which can lessen the burning sensation. Cooling also slows some of the local metabolic activity that sustains inflammation. Moisturizers or bland emollients support the impaired stratum corneum by reducing transepidermal water loss. When the barrier is less permeable, the skin becomes less dry and tight, and the inflammatory cycle is less likely to be amplified by surface irritation.
Nonsteroidal anti-inflammatory drugs, such as ibuprofen or naproxen, are often used for pain and swelling. These medications inhibit cyclooxygenase enzymes, which reduces prostaglandin synthesis. Prostaglandins are major mediators of the vasodilation and pain associated with sunburn, so lowering their production can decrease erythema and tenderness. Their effect is systemic rather than purely local, which can be useful when the inflammatory response is widespread across a large skin area.
Topical corticosteroids are sometimes considered in clinical practice for inflammatory skin reactions, though their role in sunburn is limited and they are not uniformly effective once injury is established. Corticosteroids suppress the transcription of many inflammatory genes, reducing cytokine production and leukocyte recruitment. In theory, this targets the inflammatory amplification that follows ultraviolet injury. Their ability to alter established sunburn is modest because the primary DNA and membrane damage has already occurred by the time symptoms become apparent.
Oral or topical analgesics may be used when pain is the dominant symptom. Analgesics do not repair tissue directly, but they reduce perception of nociceptive signals generated by sensitized cutaneous nerves. This matters because sunburn pain is partly the result of inflammatory mediators lowering the threshold for pain fibers in the skin. By decreasing pain signaling, these agents improve function while the underlying inflammation resolves.
Hydration support is another common component of treatment. Sunburn increases insensible water loss through damaged skin, and some people also become dehydrated because they have spent time in hot environments. Adequate fluid replacement supports circulation, tissue perfusion, and thermoregulation. When severe burns are extensive, fluid loss can become clinically relevant, and treatment then shifts from comfort measures to physiologic stabilization.
Antihistamines are occasionally used when itching becomes prominent during healing. Itching is often related to the repair phase, when new epidermal layers form and nerve endings remain temporarily sensitized. Antihistamines blunt histamine-mediated itch perception, although histamine is not the principal driver of sunburn itself. Their value is therefore symptom-specific rather than causal.
Blister care agents are sometimes used in supervised settings when blisters are present. The biology here is straightforward: blistering reflects separation within the epidermis caused by more severe cell injury and fluid accumulation. Treatment focuses on protecting the roof of the blister as a biologic dressing when possible, because the intact blister wall limits exposure of deeper tissue and reduces infection risk. Antiseptic or protective dressings may be used when the skin surface is compromised.
Procedures or Interventions
Sunburn rarely requires procedural treatment, but more severe cases may need clinical intervention. Large blistering areas, signs of infection, marked dehydration, or systemic symptoms can justify medical evaluation. In these situations, the intervention is aimed not at cosmetic recovery but at preventing complications arising from barrier failure and inflammatory stress.
Blister drainage may be performed by clinicians in selected cases when blisters are large, painful, or at risk of rupture in an uncontrolled setting. The procedure reduces pressure within the fluid-filled space while preserving the overlying skin if possible. The retained blister roof functions as a semi-occlusive barrier, limiting microbial entry and water loss. If a blister ruptures, the exposed dermis is more vulnerable to infection and evaporation, so careful wound management becomes more important.
Wound dressing and debridement are used when the skin surface has broken down. Dressings create a controlled healing environment by maintaining moisture balance and shielding damaged tissue from mechanical trauma. If loose necrotic tissue is present, debridement may be considered to remove nonviable material that would otherwise sustain inflammation or microbial growth. These measures support re-epithelialization, the process by which new keratinocytes migrate across the wound bed to restore the epidermal barrier.
Intravenous fluids may be required in cases of extensive sunburn with dehydration or heat illness. Fluid replacement restores intravascular volume, improves tissue perfusion, and helps maintain electrolyte balance. This intervention addresses the systemic physiologic consequences of widespread skin injury and heat exposure. It is most relevant when the burn covers large body areas or is accompanied by vomiting, dizziness, weakness, or reduced urine output.
Assessment for infection can be an important clinical intervention when blistered skin becomes increasingly red, warm, or painful after the initial injury phase. Infection does not occur in every case, but broken skin provides an entry point for bacteria. Clinical assessment determines whether antimicrobial treatment is needed. This step matters because secondary infection can prolong inflammation and delay barrier restoration.
Supportive or Long-Term Management Approaches
Supportive management focuses on protecting the healing skin and reducing additional ultraviolet injury while the inflammatory response resolves. The skin’s recovery depends on keratinocyte replacement, normalization of vascular tone, and restoration of the outer barrier. Any repeated UV exposure during this period can reactivate inflammation and extend tissue damage, which is why ongoing protection is biologically relevant to treatment even though it does not directly reverse the original injury.
Ongoing management may include the use of bland skin-care products that do not irritate the damaged epidermis. Harsh cleansers, alcohol-based preparations, and fragranced products can disrupt the recovering barrier and worsen transepidermal water loss. In contrast, gentle, non-irritating products reduce frictional stress on sensitized skin.
Follow-up care is more important in extensive sunburn, recurrent episodes, or cases with blistering. Clinicians may monitor for delayed complications such as infection, persistent pain, or unusual healing patterns. This monitoring reflects the fact that the biological consequences of ultraviolet injury can evolve over several days, with inflammation, desquamation, and re-epithelialization occurring in sequence rather than all at once.
Long-term management also includes identifying patterns of cumulative ultraviolet exposure. Repeated sunburns contribute to epidermal DNA damage, accelerated photoaging, and increased skin cancer risk over time. Although those outcomes are not the immediate treatment target in an acute episode, they shape the broader management strategy because preventing future injury reduces cumulative biologic damage to the skin.
Factors That Influence Treatment Choices
Severity is the most important factor. Mild sunburn with limited redness and tenderness usually responds to local cooling and anti-inflammatory symptom control. More severe sunburn, especially when blistering, swelling, or systemic symptoms are present, suggests deeper epidermal damage and a greater inflammatory burden, making medical assessment more likely. The extent of skin involvement matters because larger areas of injury produce greater fluid loss and a larger inflammatory load.
The stage of the condition also affects treatment selection. Early after ultraviolet exposure, the inflammatory cascade is still developing, and symptom control is the main objective. Later, when peeling and re-epithelialization dominate, the focus shifts toward protecting the healing barrier and preventing infection. Treatments are therefore chosen according to which physiologic phase is most active.
Age and baseline health influence risk. Children, older adults, and people with impaired mobility or chronic illness may have less physiologic reserve to tolerate dehydration or extensive pain. Conditions that affect immune function, circulation, or skin integrity can also alter healing and raise complication risk. Prior reactions to medications or previous failure of symptom control may further shape the approach.
The presence of related medical conditions matters as well. Heat exhaustion, heat stroke, or skin disorders can coexist with sunburn and change the clinical picture. A person with fever and dizziness may need evaluation for systemic heat injury rather than simple cutaneous inflammation alone. Treatment choices follow the combined physiologic stress rather than the burn in isolation.
Potential Risks or Limitations of Treatment
Most sunburn treatments are supportive, so their main limitation is that they do not fully reverse cellular injury once UV damage has occurred. Cooling and anti-inflammatory medications improve symptoms, but the epidermis still needs time to regenerate. The healing process cannot be accelerated indefinitely because keratinocyte migration and differentiation follow biologic constraints.
Medications can also carry risks. Nonsteroidal anti-inflammatory drugs may irritate the stomach, affect kidney function, or interact with other conditions that alter fluid balance. Topical corticosteroids can thin the skin if used inappropriately, and their benefit for established sunburn is limited. Antihistamines may cause sedation, which is a pharmacologic effect rather than a direct treatment problem, but it can still affect how the person functions during recovery.
Procedural interventions have their own limitations. Blister drainage or wound care can introduce infection if sterile technique is not maintained. Removing a blister roof too early can expose deeper tissue and slow healing. Intravenous fluids are useful only when dehydration or systemic illness is present; they do not address local epidermal injury. Because sunburn is often self-limited, aggressive intervention is reserved for cases where the physiologic burden justifies it.
Another limitation is that treatment cannot erase the cumulative DNA damage created by ultraviolet radiation. Relief of symptoms does not eliminate the longer-term biological consequences of repeated exposure. This is why treatment of a single episode is only one part of the broader clinical picture.
Conclusion
Sunburn is treated by addressing the inflammatory injury caused by ultraviolet radiation and by supporting the skin while it repairs itself. The main treatment approaches include cooling, anti-inflammatory medications, moisturization, hydration support, pain control, and careful management of blistered or broken skin. In more severe cases, clinicians may need to provide wound care, fluid replacement, or infection assessment. These treatments work by reducing prostaglandin-mediated inflammation, preserving barrier function, limiting fluid loss, and preventing secondary complications.
Because sunburn is an acute tissue injury with both local and systemic effects, treatment choices depend on severity, timing, and the condition of the person affected. The overall aim is not only symptom relief but also restoration of normal skin function and reduction of the risk of further injury. The underlying biology of sunburn, especially UV-induced cellular damage and inflammatory activation, explains why treatment focuses on calming inflammation and supporting epidermal healing rather than on a single curative intervention.